Form 13F-NT Esta Investments Pte. For: Jun 30
.FormData {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
}
.FormDataC {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align: center;
}
.FormDataR {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align:... (continue reading...)
Form 6-K AXIA Energia S.A. For: Jun 30
http://archive.fast-edgar.com/20260806/AF2Z822CZ22YK2ZB222922OHQVKHZZ22Z782
Filed on: August 6, 2026
Form 8-K OPEN TEXT CORP For: Aug 06
0001002638false00010026382026-08-062026-08-06 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________FORM 8-K ______________________CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 6, 2026 ______________________Open Text Corporation (Exact name of Registrant as specified in its charter) ______________________Canada0-2754498-0154400(State... (continue reading...)
Form 8-K Commerce.com, Inc. For: Aug 06
0001626450false0001626450bigc:SeriesOneCommonStockMember2026-08-062026-08-060001626450bigc:SeriesAJuniorParticipatingPreferredStockMember2026-08-062026-08-0600016264502026-08-062026-08-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 6, 2026
Commerce.com, Inc.
(Exact name of... (continue reading...)
Form 8-K Vistance Networks, Inc. For: Aug 04
0001517228false00015172282026-08-042026-08-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 4, 2026
Vistance Networks, Inc.
(Exact name of Registrant as Specified in Its Charter)
Delaware
001-36146
27-4332098
(State... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Cullinan Therapeutics, For: Aug 06
-
Form 8-K Zoetis Inc. For: Aug 06
-
Form 8-K Smith Douglas Homes Corp For: Aug 06
-
Form SC TO-T Forte Biosciences, Inc. Filed by: ARGENX SE
-
Form 8-K Shift4 Payments, Inc. For: Aug 06
-
Form 10-Q TripAdvisor, Inc. For: Jun 30
-
Form 8-K Core Natural Resources, For: Aug 06
-
Form 10-Q Cartesian Therapeutics, For: Jun 30
-
Form 13F-NT Ellington Investments For: Jun 30
-
Form 8-K BENTLEY SYSTEMS INC For: Aug 06
-
Form 8-K Resolute Holdings Manage For: Aug 06
-
Form 6-K Pony AI Inc. For: Aug 06
-
Form 8-K Vital Farms, Inc. For: Aug 03
-
Form 13F-HR Marcho Partners LLP For: Jun 30
-
Form 10-Q PAPA JOHNS INTERNATIONAL For: Jun 28
-
Form 8-K IOVANCE BIOTHERAPEUTICS, For: Aug 06
-
Form 10-Q Immunocore Holdings plc For: Jun 30
-
Form 8-K BlackSky Technology Inc. For: Aug 06
-
Form 8-K Tecnoglass Holdings Inc. For: Aug 06
-
Form 8-K Viridian Therapeutics, For: Aug 06
-
Form 8-K LIGAND PHARMACEUTICALS For: Aug 06
-
Form 10-Q CPI Card Group Inc. For: Jun 30
-
Form 8-K Opus Genetics, Inc. For: Aug 06
-
Form 8-K Warner Bros. Discovery, For: Aug 06
-
Form 13F-NT Dahlia Investments Pte. For: Jun 30
-
Form 10-Q Amylyx Pharmaceuticals, For: Jun 30
-
Form 8-K Korro Bio, Inc. For: Aug 05
-
Form 10-Q Avalo Therapeutics, Inc. For: Jun 30
-
Form 8-K Monte Rosa Therapeutics, For: Aug 06
-
Form 8-K Evolent Health, Inc. For: Aug 06
-
Form 8-K Cartesian Therapeutics, For: Aug 06
-
Form 8-K GPGI, Inc. For: Aug 06
-
Form 8-K NEXSTAR MEDIA GROUP, For: Aug 06
-
Form 8-K Unity Software Inc. For: Aug 06
-
Form 8-K ADVANCED DRAINAGE SYSTEM For: Aug 06
-
Form 10-Q Foghorn Therapeutics For: Jun 30
-
Form 13F-NT Canhill Investments Pte. For: Jun 30
-
Form 8-K Cooper-Standard Holdings For: Aug 05
-
Form 8-K BKV Corp For: Aug 06
-
Form 8-K LAMAR ADVERTISING CO/NEW For: Aug 06
-
Form 8-K Keurig Dr Pepper Inc. For: Aug 06
-
Form 8-K Amylyx Pharmaceuticals, For: Aug 06
-
Form 8-K TIC Solutions, Inc. For: Aug 06
-
Form 8-K CPI Card Group Inc. For: Aug 06
-
Form 8-K Foghorn Therapeutics For: Aug 06
-
Form 8-K Avalo Therapeutics, Inc. For: Aug 06
-
Form 13F-NT Birchtree Fund Investmen For: Jun 30
-
Form 10-Q Kenvue Inc. For: Jun 28
-
Form 8-K TripAdvisor, Inc. For: Aug 06
-
Form 8-K Immunocore Holdings plc For: Aug 06
